Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Discontinued | 003 |
Application Products
001 | TABLET;ORAL | 250MG | 1 | PEGANONE | ETHOTOIN |
003 | TABLET;ORAL | 500MG | 0 | PEGANONE | ETHOTOIN |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1957-04-22 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1980-02-05 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1982-07-12 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 1982-11-04 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 1983-10-28 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 12 | AP | 1984-11-13 | PRIORITY |
LABELING; Labeling | SUPPL | 13 | AP | 2003-09-26 | |
LABELING; Labeling | SUPPL | 14 | AP | 2003-09-26 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 15 | AP | 1998-05-13 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 16 | AP | 2002-04-04 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 17 | AP | 2002-12-10 | PRIORITY |
LABELING; Labeling | SUPPL | 20 | AP | 2007-02-02 | STANDARD |
LABELING; Labeling | SUPPL | 21 | AP | 2009-04-23 | 901 REQUIRED |
LABELING; Labeling | SUPPL | 22 | AP | 2010-06-07 | STANDARD |
REMS; REMS | SUPPL | 23 | AP | 2011-05-31 | N/A |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 24 | AP | 2013-01-23 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 25 | AP | 2017-02-27 | N/A |
Submissions Property Types
SUPPL | 5 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 0 |
SUPPL | 11 | Null | 0 |
SUPPL | 12 | Null | 0 |
SUPPL | 15 | Null | 0 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 0 |
SUPPL | 22 | Null | 7 |
SUPPL | 23 | Null | 6 |
SUPPL | 24 | Null | 0 |
SUPPL | 25 | Null | 15 |
CDER Filings
RECORDATI RARE
cder:Array
(
[0] => Array
(
[ApplNo] => 10841
[companyName] => RECORDATI RARE
[docInserts] => ["Medication Guide","http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/010841s022MedGuide.pdf"]
[products] => [{"drugName":"PEGANONE","activeIngredients":"ETHOTOIN","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"PEGANONE","activeIngredients":"ETHOTOIN","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"06\/07\/2010","submission":"SUPPL-22","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/010841s022lbl.pdf\"}]","notes":""},{"actionDate":"06\/07\/2010","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/010841s022lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/010841s021lbl.pdf\"}]","notes":""},{"actionDate":"02\/02\/2007","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/010841s020lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"PEGANONE","submission":"ETHOTOIN","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"PEGANONE","submission":"ETHOTOIN","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2010-06-07
)
)